•
Jun 30, 2018

ResMed Q4 2018 Earnings Report

Total Revenue
$624M
Previous year: $557M
+12.0%
EPS
$0.95
Previous year: $0.77
+23.4%
Gross Profit
$362M
Previous year: $324M
+12.0%
Cash and Equivalents
$189M
Previous year: $822M
-77.0%
Free Cash Flow
$112M
Previous year: $122M
-8.3%
Total Assets
$3.06B
Previous year: $3.47B
-11.7%

ResMed

ResMed